Integrative Computational In-depth Analysis of Dysregulated MiRNA-mRNA Interactions in Drug-resistant Pediatric Acute Lymphoblastic Leukemia Cells: an Attempt to Obtain New Potential Gene-miRNA Pathways Involved in Response to Treatment

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2015 Dec 25

PMID 26700663

Citations 13

Authors

Hamzeh Mesrian Tanha

Marjan Mojtabavi Naeini

Soheila Rahgozar

Alireza Moafi

Mohammad Amin Honardoost

Affiliations

Soon will be listed here.

Abstract

Acute lymphoblastic leukemia (ALL) is the major neoplasia type among children. Despite the tremendous success of current treatment strategies, drug resistance still remains a major cause of chemotherapy failure and relapse in pediatric patients. Overwhelming evidence illustrates that microRNAs (miRNAs) act as post-transcriptional regulators of drug-resistance-related genes. The current study was aimed at how dysregulated miRNA-mRNA-signaling pathway interaction networks mediate resistance to four commonly used chemotherapy agents in pediatric ALL, including asparaginase, daunorubicin, prednisolone, and vincristine. Using public expression microarray datasets, a holistic in silico approach was utilized to investigate candidate drug resistance miRNA-mRNA-signaling pathway interaction networks in pediatric ALL. Our systems biology approach nominated significant drug resistance and cross-resistance miRNAs, mRNAs, and cell signaling pathways based on anti-correlative relationship between miRNA and mRNA expression pattern. To sum up, our systemic analysis disclosed either a new potential role of miRNAs, or a possible mechanism of cellular drug resistance, in chemotherapy resistance of pediatric ALL. The current study may shed light on predicting drug response and overcoming drug resistance in childhood ALL for subsequent generations of chemotherapies.

Citing Articles

LncRNA PTPRG-AS1 Promotes Breast Cancer Progression by Modulating the miR-4659a-3p/QPCT Axis.

Zhou M, Li Y, Yang L, Liu S, Yang L, Xu B Onco Targets Ther. 2024; 17:805-819.

PMID: 39380914 PMC: 11460282. DOI: 10.2147/OTT.S474898.

AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B.

Zhang J, Zheng Y, Liu H, Liu B Blood Lymphat Cancer. 2024; 14:17-30.

PMID: 38550556 PMC: 10976969. DOI: 10.2147/BLCTT.S454115.

Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study.

Pessoa R, de Souza D, Nukui Y, Pereira J, Fernandes L, Marcusso R Int J Mol Sci. 2023; 24(13).

PMID: 37445821 PMC: 10342019. DOI: 10.3390/ijms241310643.

Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine.

Saha Detroja T, Detroja R, Mukherjee S, Samson A Int J Mol Sci. 2022; 23(20).

PMID: 36293493 PMC: 9603969. DOI: 10.3390/ijms232012628.

MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools.

Kyriakidis I, Kyriakidis K, Tsezou A Cancers (Basel). 2022; 14(16).

PMID: 36010971 PMC: 9406077. DOI: 10.3390/cancers14163976.

References

Bousquet M, Harris M, Zhou B, Lodish H . MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci U S A. 2010; 107(50):21558-63. PMC: 3003065. DOI: 10.1073/pnas.1016611107. View

Suraweera A, Munch C, Hanssum A, Bertolotti A . Failure of amino acid homeostasis causes cell death following proteasome inhibition. Mol Cell. 2012; 48(2):242-53. PMC: 3482661. DOI: 10.1016/j.molcel.2012.08.003. View

Bachur N, Gordon S, Gee M, Kon H . NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci U S A. 1979; 76(2):954-7. PMC: 383104. DOI: 10.1073/pnas.76.2.954. View

Akbari Moqadam F, Lange-Turenhout E, Aries I, Pieters R, den Boer M . MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia. Leuk Res. 2013; 37(10):1315-21. DOI: 10.1016/j.leukres.2013.06.027. View

Gillet J, Gottesman M . Mechanisms of multidrug resistance in cancer. Methods Mol Biol. 2009; 596:47-76. DOI: 10.1007/978-1-60761-416-6_4. View

Kawedia J, Rytting M . Asparaginase in acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2014; 14 Suppl:S14-7. DOI: 10.1016/j.clml.2014.06.017. View

Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R . Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 2004; 11 Suppl 1:S45-55. DOI: 10.1038/sj.cdd.4401456. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Ueno T, Ohtawa K, Mitsui K, Kodera Y, Hiroto M, Matsushima A . Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia. 1997; 11(11):1858-61. DOI: 10.1038/sj.leu.2400834. View

10.

Hsu S, Tseng Y, Shrestha S, Lin Y, Khaleel A, Chou C . miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2013; 42(Database issue):D78-85. PMC: 3965058. DOI: 10.1093/nar/gkt1266. View

11.

Pieters R, Huismans D, Loonen A, Hahlen K, van der Does-van den Berg A, van Wering E . Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet. 1991; 338(8764):399-403. DOI: 10.1016/0140-6736(91)91029-t. View

12.

Brekken R . Faulty ECM signaling facilitates autoimmune lymphomagenesis. Cancer Discov. 2014; 4(1):25-6. DOI: 10.1158/2159-8290.CD-13-0912. View

13.

Kaspers G, Veerman A, Pieters R, van Zantwijk C, Smets L, van Wering E . In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 1997; 90(7):2723-9. View

14.

Matloub Y, Lindemulder S, Gaynon P, Sather H, La M, Broxson E . Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic.... Blood. 2006; 108(4):1165-73. PMC: 1895867. DOI: 10.1182/blood-2005-12-011809. View

15.

Ploner C, Schmidt S, Presul E, Renner K, Schrocksnadel K, Rainer J . Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J Steroid Biochem Mol Biol. 2005; 93(2-5):153-60. DOI: 10.1016/j.jsbmb.2004.12.017. View

16.

Holleman A, Cheok M, den Boer M, Yang W, Veerman A, Kazemier K . Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med. 2004; 351(6):533-42. DOI: 10.1056/NEJMoa033513. View

17.

Moschovi M, Critselis E, Cen O, Adamaki M, Lambrou G, Chrousos G . Drugs acting on homeostasis: challenging cancer cell adaptation. Expert Rev Anticancer Ther. 2015; 15(12):1405-17. DOI: 10.1586/14737140.2015.1095095. View

18.

van Dongen J . Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta. 1991; 198(1-2):93-174. DOI: 10.1016/0009-8981(91)90247-a. View

19.

Holohan C, Van Schaeybroeck S, Longley D, Johnston P . Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013; 13(10):714-26. DOI: 10.1038/nrc3599. View

20.

Gulino R, Forte S, Parenti R, Memeo L, Gulisano M . MicroRNA and pediatric tumors: Future perspectives. Acta Histochem. 2015; 117(4-5):339-54. DOI: 10.1016/j.acthis.2015.02.007. View